Hospitals are losing more money from bad debt and write-offs despite investing billions into automation to improve financial performance and remain competitive in the AI arms race.

Unos científicos han conseguido visualizar y describir cómo la bacteria Thomasclavelia ramosa, que se halla habitualmente en el intestino humano, consigue romper los anticuerpos de la inmunoglobulina IgA2, una de las primeras líneas defensivas del cuerpo. Esta investigaci&oacute …

Twelve marketed drugs, including Eli Lilly’s and Novo’s weight loss mega-blockbusters, will require a label change under the new FDA update.

Un equipo de expertos ha hecho un llamamiento público advirtiendo de los riesgos que la gripe aviar acarrea para las poblaciones de buitres. Los firmantes del documento también ponen de manifiesto los problemas que el declive de los buitres puede causar en los ecosistemas y en el biene …

The Phase 3 results help clarify the safety profile of Zealand and Boehringer Ingelheim’s survodutide, but analysts do not think the drug will find utility beyond patients with liver-related risk factors.

If approved, the oral GLP-1 would be Eli Lilly’s second marketed drug for obstructive sleep apnea after the GIP/GLP-1 injectable Zepbound secured the first approval in the space in December 2024.

Conforme avanzan los preparativos de la NASA para las nuevas visitas de astronautas a la superficie lunar tras más de medio siglo de ausencia, esta agencia espacial y las empresas que están colaborando con ella, particularmente Blue Origin y SpaceX, que se ocupan de vehículos de …

The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.

A medida que avanza el calentamiento global, la gente tiende cada vez más a usar ventiladores o aparatos de aire acondicionado. Pero cuanto mayor es dicho uso, más energía es consumida y, en muchos casos, más dióxido de carbono se genera. Gracias a los continuos av …

Vir Biotechnology is targeting a mid-2027 regulatory submission for its monthly chronic hepatitis delta regimen, with head-to-head data against Gilead’s Hepcludex expected next quarter.

Hasta la fecha, se ha conseguido catalogar más de 6000 planetas de fuera de nuestro sistema solar y se buscan, en las atmósferas de los mundos más prometedores, huellas químicas de la presencia de vida. Pero no es fácil reconocer tales huellas.   El primer p …

The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

Compass Pathways has completed an FDA filing for COMP360, with an expected launch in the first half of next year. The update follows a reported regulatory submission for Usona Institute’s own psilocybin candidate for depression last Monday.

The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical devices with autonomous or remote teleoperation functions.

A Phase 3 trial showed that Johnson & Johnson and Protagonist Therapeutics’ oral therapy Icotyde improved psoriatic arthritis symptoms but AbbVie’s injectable is likely to hold court based on higher efficacy, analysts say.

Full data from the Phase 3 HORIZON trial of Novartis’ pelacarsen failed to show any apparent benefit, leading analysts to further reduce the odds of success for Lp(a)-lowering competitors such as Amgen’s olpasiran.

Unnatural Products has risen from founder Joshua Schwochert’s garage to an acquisition deal, valued at up to $1.15 billion, to join argenx.

Amazon Web Services will distribute the funds as credits rather than cash to organizations working on care access, women’s and children’s health and food insecurity.

As scrutiny over cost and quality at private equity-backed hospitals persists, a new tracker shows that PE hospital ownership has expanded nationwide and is concentrated among a handful of firms.

The agency is delaying the end of Medicare payments for third-party remote patient monitoring services until 2029 following outcry from the virtual care industry.

After Novartis confirmed the reports of tumors in patients who have been treated with the spinal muscular atrophy gene therapy, the FDA will determine if any regulatory action is needed for Zolgensma or for the pharma’s similar product Itvisma.

Follow along as BioSpace tracks job cuts and restructuring initiatives.

At the American Heart Association conference, investigators were supportive of further studying Novo’s IL-6 inhibitor ziltivekimab in patients with less severe cardiovascular and kidney disease.

Basta con observar con atención una página web bien diseñada, una presentación profesional o el catálogo de una tienda en línea para notar algo curioso: las imágenes parecen pertenecer al lugar donde están. El producto flota sobre la pág …